Lung cancer starts in your lungs and can spread to other parts of your body. There are more than 20 kinds of lung cancer. Some other conditions can have similar warning signs to lung cancer.

Occasionally, this approach delivers options that are entirely chemo-free, too — helping ... has built a distinguished portfolio of lung cancer therapies across multiple stages of disease.

Lung cancer drug sugemalimab has delivered positive results following a phase 3 trial. The GEMSTONE-302 study evaluated the efficacy and safety of the investigational anti-PD-L1 antibody ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

At only age 28, the newlywed and busy teacher initially dismissed her symptoms. As her cough and fatigue worsened, she finally saw her primary care doctor.

Chemo-immunotherapy is the current first-line treatment for patients with extensive-stage small cell lung cancer (ES-SCLC), but survival benefits are ...

They block proteins, genes, and other substances that lung cancer needs to grow. Because these treatments are more focused on cancer cells, they may cause less severe side effects than chemo.

In part, that is because the addition of chemo adds to the side effect burden on patients. There are around 200,000 people diagnosed with lung cancer in the US each year, with 80-85% of them ...

A treatment for patients living with advanced non-small cell lung cancer (NSCLC) who failed two or more standard-of-care (SOC) options could extend overall survival (OS) to 16.9 months according ...

SAVANNAH Phase II trial demonstrated high and durable response rates with savolitinib plus TAGRISSO® in MET-high lung cancer, representing a ...